Close Menu

NEW YORK (360Dx) – Sygnis today reported a sharp increase in its third quarter and nine-month revenues.

For the three months ended Sept. 30, the Heidelberg, Germany-based firm said that revenues reached €2.4 million ($2.8 million), up 446 percent from the year-ago period. Sygnis did not disclose its Q3 2016 revenue figure.

For the nine months ended Sept. 30, the company reported revenues grew to €5.3 million, up from €976,000 from a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.